Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SWS Hemodialysis Care CoSHSE:688410 -4.38%88 Cyclically Adjusted PS Ratio is 12.26 as of Aug. 23, 2026, which is 9% below its 10-year median of 13.40. GuruFocus rates SHSE:688410 with a GF Score™ of 88/100 and a GF Value™ of ¥15.70 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 523 Medical Devices & Instruments companies, SWS Hemodialysis Care Co ranks worse than 90.06% on this metric.
The historical rank and industry rank for SWS Hemodialysis Care Co's Cyclically Adjusted PS Ratio or its related term are showing as below:
SHSE:688410'
s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 9.66 Med: 13.4 Max: 20.94
Current: 12.29
During the past 12 years, SWS Hemodialysis Care Co's highest Cyclically Adjusted PS Ratio was 20.94. The lowest was 9.66. And the median was 13.40.
SHSE:688410's Cyclically Adjusted PS Ratio is ranked worse than 90.06% of 523
companies
in the Medical Devices & Instruments industry
Industry Median: 2.23
vs SHSE:688410: 12.29
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.
SWS Hemodialysis Care Co's adjusted revenue per share data of for the fiscal year that ended in Dec25 was ¥1.813. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ¥0.89 for the trailing ten years ended in Dec25.
Shiller PE for Stocks: The True Measure of Stock Valuation
SWS Hemodialysis Care Co (SHSE:688410) Cyclically Adjusted PS Ratio Explanation
Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.
SWS Hemodialysis Care Co Cyclically Adjusted PS Ratio Related Terms
SWS Hemodialysis Care Co Cyclically Adjusted PS Ratio Historical Data
* Premium members only.
The historical data trend for SWS Hemodialysis Care Co's Cyclically Adjusted PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SWS Hemodialysis Care Co Cyclically Adjusted PS Ratio Chart
SHSE:688410 vs ISRG, BDX, MDLN: Cyclically Adjusted PS Ratio Comparison
For the Medical Instruments & Supplies subindustry, SWS Hemodialysis Care Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SWS Hemodialysis Care Co Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SWS Hemodialysis Care Co's Cyclically Adjusted PS Ratio distribution charts can be found below:
* The bar in red indicates where SWS Hemodialysis Care Co's Cyclically Adjusted PS Ratio falls into.
SWS Hemodialysis Care Co Cyclically Adjusted PS Ratio Calculation
Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
What does a Cyclically Adjusted PS Ratio of 12.26 mean?
SWS Hemodialysis Care Co (SHSE:688410) has a Cyclically Adjusted PS Ratio of 12.26 as of Aug. 23, 2026. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on SWS Hemodialysis Care Co and its competitors. This is near median its historical median of 13.40. Over the past decade, SWS Hemodialysis Care Co's Cyclically Adjusted PS Ratio has ranged from 9.66 to 20.94. According to the industry distribution chart, SWS Hemodialysis Care Co ranks #471 out of 523 companies in the Medical Devices & Instruments industry, placing it in the top 90.1%.
Is SWS Hemodialysis Care Co's Cyclically Adjusted PS Ratio too high?
SWS Hemodialysis Care Co's current Cyclically Adjusted PS Ratio of 12.26 is near median its 10-year median of 13.40. Over the past 10 years, this metric has ranged from a low of 9.66 to a high of 20.94. The Medical Devices & Instruments industry median Cyclically Adjusted PS Ratio is 2.23. SWS Hemodialysis Care Co's value of 12.26 is 449.8% above this industry median. Based on the distribution chart, SWS Hemodialysis Care Co ranks #471 out of 523 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, SWS Hemodialysis Care Co has a GF Score™ of 88/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SWS Hemodialysis Care Co's Cyclically Adjusted PS Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, SWS Hemodialysis Care Co ranks #471 out of 523 companies for Cyclically Adjusted PS Ratio. This places SWS Hemodialysis Care Co in the lower half of its industry. The industry median Cyclically Adjusted PS Ratio is 2.23. SWS Hemodialysis Care Co's value of 12.26 is 449.8% above this benchmark. Historically, SWS Hemodialysis Care Co's own Cyclically Adjusted PS Ratio has ranged from 9.66 to 20.94 over the past decade. While the company's 10-year median is 13.40 vs. the industry median of 2.23, SWS Hemodialysis Care Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PS Ratio for a Medical Devices & Instruments company?
The median Cyclically Adjusted PS Ratio among Medical Devices & Instruments companies is 2.23, based on 523 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SWS Hemodialysis Care Co's current Cyclically Adjusted PS Ratio of 12.26 is 449.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PS Ratio mean?
A high Cyclically Adjusted PS Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on SWS Hemodialysis Care Co and its competitors. For the Medical Devices & Instruments industry, the median Cyclically Adjusted PS Ratio is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SWS Hemodialysis Care Co's current Cyclically Adjusted PS Ratio is 12.26, which is near median its own 10-year median of 13.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SWS Hemodialysis Care Co stock overvalued right now?
Based on GuruFocus' analysis, SWS Hemodialysis Care Co (SHSE:688410) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥15.70, compared to a current price of ¥10.91 — trading 30.5% below its estimated fair value. The current Cyclically Adjusted PS Ratio is 12.26, which is near median its 10-year median of 13.40 and 449.8% above the Medical Devices & Instruments industry median of 2.23. SWS Hemodialysis Care Co's overall GF Score™ is 88/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PS Ratio calculated?
Cyclically Adjusted PS Ratio is calculated from a company's financial statements. For SWS Hemodialysis Care Co (SHSE:688410), the current Cyclically Adjusted PS Ratio is 12.26 as of Aug. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SWS Hemodialysis Care Co (SHSE:688410) Overvalued in 2026?
Based on GuruFocus' analysis, SWS Hemodialysis Care Co stock appears to be undervalued.
The current stock price of ¥10.91 is trading 30.5% below its estimated GF Value™ of ¥15.70.
GuruFocus considers SWS Hemodialysis Care Co to be Significantly Undervalued.
Key valuation signals for SHSE:688410:
Cyclically Adjusted PS Ratio: 12.26 (near median its 10-year median of 13.40)
GF Value™: ¥15.70 vs. price of ¥10.91 (30.5% below fair value)
Industry Position: 449.8% above the Medical Devices & Instruments median (#471 of 523)
No single metric tells the full story. See the SHSE:688410 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SWS Hemodialysis Care Co Ltd along with its subsidiaries is engaged in the field of blood purification. Its focused on patients welfare and ensuring the delivery of safe and effective products and services. The group operates through four segments: Blood Purification Equipment, Blood Purification Consumables, advanced Hemodialysis Management System, and Chain Dialysis centers. The organization is delivering medical solutions for patients with chronic kidney disease (CKD). Its products include Blood Purification Equipment Dialysis, Disposables Dialysis Center, Intelligent Management System, and Chain Dialysis centers. SWS is committed to enhancing patient wellness by prioritizing care through advanced integrated blood purification technologies.
88GF Score
Get the complete analysis for SHSE:688410
Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688410 has been successfully added to your 
